Back

Primary prevention of sudden cardiac death in in hypertrophic cardiomyopathy: are we calibrating arrhythmic risk correctly?

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in device therapy (1) Implantable Cardioverter-Defibrillator (ICD) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail
Assessing compliance with ESC 2021 guidelines for cardiac Investigations prior to permanent pacemaker implantation
Miss H. Emkidh (Glasgow, GB)
Abstract
Presentation thumbnail
Efficacy and safety of extravascular defibrillation (EV-ICD) implantation in young patients: a single-center experience
Doctor G. Papingiotis (Athens, GR)
Abstract
Presentation thumbnail
Extravascular implantable cardioverter-defibrillators in children: case series and systematic review
Mr P. Mangas Palma (Porto, PT)
Abstract
Presentation thumbnail
Left ventricular-only pacing in CRT-D: insights into arrhythmic burden
Doctor D. Anutoni (Timisoara, RO)
Abstract
Presentation thumbnail
Predictors of electrical response in left bundle branch pacing
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
ePosters in device therapy (1)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources